Introduction
============

Bacterial resistance has become one of the most important issues in the global medical field. It differs in various regions and is related with many social factors.^[@B1]^ Analysis of the resistance can assist to observe the characteristics and changes of the bacterial resistance. Besides, it can provide real-time reference for the clinical application of antibiotics and enhance the monitoring of the distribution of common bacteria, which can offer epidemiology data and changes of bacterial resistance for clinic, and effectively guide the clinical treatment for pathogen infections.^[@B2],[@B3]^ The analysis of the isolated bacterial resistant in our hospital in the second half of 2011 is presented in this manuscript.

Methodology
===========

***Source of bacterial strains:***All pathogens were isolated from community-acquired infections of the patients enrolled in our hospital, and the secondary infections after being enrolled were excluded.

***Instruments and reagents:***Automatic micro-analyzer, ProtoCOL automated microbial analysis system, bacterial identification cards and drug susceptibility test cards^[@B4]^ were bought from Synbiosis (UK) Ltd. and control strains including *Staphylococcus aureus* ATCC25923, *Klebsiella pneumoniae* ATCC700603, *Escherichia coli*ATCC25922, *Pseudomonas aeruginosa* ATCC27853, *Candida albicans* ATCC90029 and *Enterococcus faecium*ATCC33186 were all purchased from Shanghai Chuan Xiang Biotech Co., Ltd.

***Drug sensitivity tests:*** Bacterial identifications and susceptibility tests were performed through Automatic micro-analyzer (British Synbiosis) and ProtoCOL automated microbial analysis system, respectively. Antimicrobial minimum inhibitory concentration (MIC) was carried out by the automatic analyzer. Drug sensitivity tests met the standards of Clinical and Laboratory Standards Institute (CLSI).^[@B5]^

***Assay methods:*** The disc confirmatory tests of ESBLs (extended spectrum β lactamases) of *Escherichia coli*, *Klebsiella pneumonia* and *Proteus mirabilis* were carried out according to CLSI2008. Quality control strains included *Escherichia coli* ATCC25922 (negative control) and *Klebsiella pneumoniae* ATCC700603 (positive control). PRSP (penicillin resistant *Streptococcus pneumoniae*) were detected by Optoching antibacterial tests and *Streptococcus pneumoniae* monoclonal latex agglutination tests. Drug sensitive test of *Streptococcus pneumoniae* was carried out by ATB-STREP5-test paper, and *Streptococcus pneumoniae* were divided into three categories: penicillin-susceptible strains (PSSP), penicillin-intermediate strains (PISP) and penicillin-resistant strains (PRSP).^[@B6]^

***Statistical analysis:*** The results were analyzed by one-way ANOVA for multiple comparisons by SPSS. A P-value \< 0.05 was considered significant.

Results
=======

A total of 1096 isolates were collected in the second half of 2011, the sources of the strains included respiratory secretions (68.80%), urine (15.69%), blood (12.14%) and others (3.38%).

In the 1096 isolates, gram negative and gram positive bacteria accounted for 54.20% and 37.50% respectively, fungi accounted for 8.30%. In the gram negative bacteria, the proportion of *Enterobacteriaceae* was 55.89%, and those of non-fermenting gram negative bacilli and other species were 34.51% and 9.60%, respectively. In the gram positive bacteria, *Staphylococcus*, *Coagulase-negative staphylococci*, *Enterococcus* and *Streptococcus pneumonia* accounted for 32.85%, 40.39%, 12.41% and 10.22% respectively, other species accounted for 4.14%. The proportions of all the bacteria are shown in [Table-I](#T1){ref-type="table"}. The main pathogens, including *E. coli*, *Staphylococcus aureus*, *Klebsiella pneumoniae*, *Pseudomonas aeruginosa*, *Candida albicans* and *Acinetobacter baumannii*, occurred following a decreasing frequency.

###### 

Distribution of 1096 strains of pathogenic bacteria

  *Pathogen*                         *No. of strains*   *Proportion (%)*
  ---------------------------------- ------------------ ------------------
  Gram negative bacteria             594                54.20
  Enterobacteriaceae                 332                30.29
  E. coli                            153                13.96
  Klebsiella pneumoniae              92                 8.39
  Others                             87                 7.94
  NFGNB                              205                18.70
  Pseudomonas aeruginosa             74                 6.75
  Acinetobacter baumannii            62                 5.66
  Others                             69                 6.30
  Others                             57                 5.20
  Gram positive bacteria             411                37.50
  Staphylococcus aureus              135                12.14
  Coagulase-negative staphylococci   166                15.23
  Staphylococcus epidermidis         52                 4.74
  Staphylococcus haemolyticus        51                 4.65
  Others                             63                 5.75
  Enterococcus                       51                 4.65
  Pneumonia hammer                   42                 3.83
  Others                             17                 1.55
  Fungi                              91                 8.30
  Candida albicans                   66                 6.02
  Candida glabrata                   18                 1.64
  Others                             7                  0.64

***Resistance of gram negative bacilli to antibiotics:*** Top five of the selected gram negative bacilli were *Klebsiella pneumoniae*, *Pseudomonas aeruginosa*, *Acinetobacter baumannii*, *Escherichia coli* and *Proteus mirabilis*, respectively. Susceptibility tests showed that *Klebsiella pneumoniae* was sensitive to amikacin, cefepime and imipenem (the resistance rate \<20%), whereas it was highly resistant to ampicillin. The detection rates of ESBLs from *Escherchia coli*, *Pseudomonas aeruginosa* and *Klebsiella pneumoniae* were 54.51%, 52.08% and 38.65%, respectively. *Pseudomonas aeruginosa* was sensitive to cefepime and imipenem, whereas it exhibited high resistance to cefoperazone/tazobactam and cefotaxime. *Acinetobacter baumannii* as well as *Escherichia coli* were resistant to most antibiotics ([Table-II](#T2){ref-type="table"}).

###### 

Resistance rates of gram-negative bacteria to antibiotics (%).

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *Antibiotic*               *Klebsiella pneumoniae (n=92)*   *Bacillus pyocyaneus (n=74)*   *Acinetobacter baumannii (n=62)*   *Escherichia coli (n=153)*   *Proteus mirabilis*\
                                                                                                                                                             *(n=32)*
  -------------------------- -------------------------------- ------------------------------ ---------------------------------- ---------------------------- ----------------------
  Amikacin                   19.57                            31.08                          48.39                              23.53                        25.00

  Ampicillin                 94.57                            91.89                          96.78                              90.20                        90.63

  Aztreonam                  61.96                            85.90                          67.74                              71.90                        34.38

  Ceftazidime                34.78                            33.78                          79.03                              70.59                        40.63

  Cefotaxime                 33.70                            29.73                          75.81                              57.52                        43.75

  Cefoperazone/ Tazobactam   27.17                            28.38                          70.97                              50.98                        31.25

  Cefepime                   19.57                            18.92                          38.71                              33.99                        21.88

  Imipenem                   10.87                            12.16                          24.19                              28.76                        15.63

  Gentamicin                 29.35                            28.38                          62.90                              66.67                        46.88

  Ciprofloxacin              26.09                            24.32                          64.74                              64.71                        40.63

  Levofloxacin               21.74                            25.68                          72.58                              73.20                        34.38
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

***Resistance of gram-positive cocci to antibiotics:*** Gram positive cocci mainly consisted of *Staphylococcus aureus*, *Staphylococcus epidermidis* and *Enterococcus*. *Staphylococcus aureus* was sensitive to fusidic acid, vancomycin and teicoplanin, but showed high resistant rates to β-lactams, macrolides, quinolones and aminoglycosides. *Staphylococcus epidermidis* was highly resistant to a variety of antibiotics, and *Enterococci*was resistant to traditional antibiotics. Susceptibility tests showed the detection rates of MRSA and MRCNS were 60.13% and 85.54%, in which 38 and 39 strains were resistant to fusidic acid and vancomycin, respectively ([Table-III](#T3){ref-type="table"}).

###### 

Resistance rates of gram-positive bacteria to antibiotics (%).

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *Antibiotic*    *Staphylococcus aureus (n=92)*   *Staphylococcus epidermidis (n=74)*   *Enterococcus (n=62)*   *Streptococcus pneumoniae (n=153)*   *Staphylococcus haemolyticus (n=32)*
  --------------- -------------------------------- ------------------------------------- ----------------------- ------------------------------------ --------------------------------------
  Penicillin      95.65                            95.95                                 96.77                   96.73                                93.75

  Cefazolin       92.39                            94.60                                 80.65                   88.24                                84.38

  Gentamicin      93.48                            93.24                                 77.42                   86.27                                81.25

  Levofloxacin    83.70                            83.78                                 72.58                   78.43                                71.88

  Azithromycin    91.30                            94.60                                 82.26                   86.93                                90.63

  Ciprofloxacin   86.96                            91.89                                 95.16                   90.20                                87.50

  Cefotaxime\     81.52                            85.16                                 75.81                   75.82                                78.13
  Fusidic Acid                                                                                                                                        

  41.30           31.08                            35.48                                 50.98                   50.00                                

  Vancomycin      42.39                            35.14                                 43.55                   46.35                                53.13

  Teicoplanin     35.87                            33.78                                 38.71                   42.48                                59.38
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Discussion
==========

The emergences of NDM-1 (New Delhi-Metallo-1) bacteria worldwide that are resistant to most antibiotics have greatly threatened human health.^[@B7]^ In recent years, many antibiotics are becoming invalid confronting multi-resistant bacteria. In China, the occurrences of MRSA, MDRSP and VRE have increased tremendously and covered most of the medical institutions, even *Klebsiella pneumoniae* (KPC) has also been observed having the same tendency. In future, more super bacteria resisting to most antibiotics like NDM-1 bacteria will emerge.^[@B8],[@B9]^ Therefore, as a primary hospital, it is necessary to be aware of the distribution of common pathogens, monitor the bacterial resistance and analyze the bacterial resistance to common antibiotics.^[@B10]^

The results showed that the resistances of *Klebsiella pneumoniae* to cefoperazone/tazobactam, cefepime, imipenem, ciprofloxacin, gentamicin and levofloxacin were not very significant. Therefore, according to the principle that antibiotics should be used following a rising sensitivity order, leveofloxacin, ciprofloxacin and cefoperazone/tazobactam could be utilized first as empirical treatment against *Klebaiella*. *Pseudomonas aeruginosa* was also sensitive to the above antibiotics, but the degree was lower than that of *Klebsiella*. The drug resistance mechanism of *Pseudomonas aeruginosa* is quite complex, which will produce a variety of β-lactamase enzymes and express active efflux system.^[@B11]^ Besides, the decreased permeability of the membrane resulted from the changes of outer membrane protein and penicillin-binding protein contributes to the resistance.^[@B12]^

Therefore, the starting point of antibiotics for *Pseudomonas aeruginosa* ought to be higher than that for *Klebsiella*. *Acinetobacter baumannii* ranked second after *Pseudomonas aeruginosa* for the infections induced by non-fermenting gram-negative bacteria. *Acinetobacter* carried various drug resistance genes, which would bring about high risks to nosocomial infection.^[@B13]^ In the presence of the extensively used antibiotics, treating the infections resulted from multi-drug resistant *Acinetobacter baumannii* is becoming difficult. According to the bacterial resistance in the second half of 2011 in our hospital, *Acinetobacter baumannii* was sensitive to carbapenem antibiotics followed by second-generation cephalosporins, but it was highly resistant to other antibiotics, which should arouse the attention of primary health care institutions. *Enterobacteriaceae* bacteria were sensitive to carbapenem antibiotics, fourth generation cephalosporins and glycopeptides. The susceptibility tests showed that the sensitivity rates of *E. coli* to imipenem and cefepime were both above 70%, whereas it was highly resistant to other antibiotics. However, it is worthy to note that the resistance rates against *E. coli* in other medical institutions were generally lower than those in our hospital. ESBLs tests showed that the detection rate of ESBLs in *E. coli* was 54.51%, which may be related to the wide application of third generation cephalosporins, leading to the utilization of CTM-type ESBL produced by *E. coli* as the superior strain.^[@B14]^

During the second half of 2011, the detection rates of MRSA and MRCNS were 60.13% and 85.54%, respectively. Both the bacteria were resistant to all of the β-lactam antibiotics, and they exhibited an increasing resistance tendency to fluoroquinolones, aminoglycosides and polypeptide antibiotics. In the past year, vancomycin-resistant *Staphylococcus aureus* emerged in succession and became resistant to fusidic acid and cefepime. Therefore, it has been demonstrated that the resistance to polypeptide antibiotic was severe.^[@B15],[@B16]^

Furthermore, *Staphylococcus epidermidis* is one of the most common *Coagulase-negative staphylococci*, which can also be isolated from most of the methicillin-resistant *Coagulase staphylococcus*, and its resistance rate increases yearly.^[@B17]^ The results exhibited that except for fusidic acid and polypeptide antibiotics, the resistance of *Staphylococcus epidermidis* to other antibiotics was even higher than that of MRSA, the severity of which should not be ignored as a result. As an opportunistic pathogen, *Enterococcus* led to increasing infections every year, and its drug resistance has become extremely serious according to the results in our hospital. Vancomycin-resistant *Enterococci *was also observed in our hospital, so it is imperative to enhance the monitoring of the drug resistance. *Streptococcus pneumoniae* is the major pathogen resulting in community-acquired infections, and its resistance to antibiotics has also aroused wide concern.^[@B18]^ Many respiratory tract infections are triggered by *Streptococcus pneumonia*. Nevertheless, in the presence of the penicillin-resistant *Streptococcus pneumoniae*, long-term macrolide antibiotics have to be utilized for the treatment, which enables the *Streptococcus pneumoniae* to be resistant to macrolide antibiotics increasingly.^[@B19],[@B20]^ The results herein showed that the resistance rates of both azithromycin and quinolones were as high as that of penicillin for *Streptococcus pneumoniae*. Besides, the resistance values of *Streptococcus pneumoniae* to β-lactams, quinolones and macrolides antibiotics exceeded the national average levels.^[@B21]^

In summary, it is to reinforce the surveillance of pathogens and their drug resistance to use antibiotics rationally. Clinically, antibiotics should be used according to the results of the susceptibility tests to reduce the prevalence of drug resistant strains, which will allow us to control the increase and spread of bacterial resistance.
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